 Bloomberg [1] |
Amylin Pharma rises on report of new sale talks [2]
CBS News THE BIG PICTURE: Amylin sells the diabetes treatment [3]s Bydureon and Byetta. The company reportedly rejected a buyout offer from Bristol-Myers Squibb Co. earlier this year, and it is being sued by billionaire investor Carl Icahn. Amylin Said to Seek Buyers After Rejecting Bristol-Myers [1]Bloomberg Exclusive: Amylin explores sale, hires bankers: sources [4]Reuters Amylin Is Said to Pursue a Sale [5]New York Times all 51 news articles » [6] |
More details can be found at www.diabeteshowto.com [7]